Diagnostics companies at AMP 2026
Nov 10–14, 2026 Seattle, WA ~2k attendees Website
40 diagnostics companies are at AMP 2026 — 34 presentations on the program and 37 with a booth in the exhibit hall. Most represented: Roche Diagnostics (3 on the program), Guardant Health (2 on the program), Natera (2 on the program). 23 of them have their own page in this guide. As of Sep 25, 2026.
Program track
Top represented
Showing 1–13 of 40 organizations
| Organization | AMP 2026 Attendance |
|---|---|
Roche Diagnostics Indianapolis, IN | |
Clinical diagnostics, life science research, digital PCR and next-generation sequencing systems and assays for laboratories. | Booth Exhibiting at Booth 700 Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm 🏅Diamond Partner Workshop Wed, Nov 11 10:00am–10:50am Unlocking the Complete Lyo-Ready Workflow: From Sample Preparation to Amplification A shelf-stable reagent set spanning sample prep, reverse transcription and amplification for assays built without cold-chain storage. Workshop Wed, Nov 11 11:00am–11:50am Automated and Integrated Genomic Profiling of Hematologic Malignancies Sequencing workflows for blood cancers that report mutations, structural variants and clonal evolution in one automated run. Workshop Wed, Nov 11 12:00pm–12:50pm Next-Generation Sequencing with Roche’s AXELIOS 1 Platform Roche's AXELIOS 1 sequencer and its expansion-based chemistry, covering accuracy, read length and run flexibility. Workshop Wed, Nov 11 1:00pm–1:50pm Versatile Whole-exome Sequencing Enables End-to-end Phenotype-driven DNA-variant identification or RNA-fusion detection Phenotype-driven exome workflows for germline variant discovery, plus two RNA-sequencing routes to fusions. Workshop Wed, Nov 11 9:00am–9:50am Advancing HLA Class I Typing Through Comprehensive Genomic Profiling Adding HLA class I typing to comprehensive genomic profiling, with immuno-oncology uses from checkpoint inhibitors to cell therapy. |
Guardant Health Palo Alto, CA | |
Precision oncology company offering blood and tissue tests, real-world data and AI analytics for cancer care. | Booth Exhibiting at Booth 1043 Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm Workshop Wed, Nov 11 2:00pm–2:50pm Building Scalable Clinical Genomics Workflows: Practical Lessons from Leading Laboratories Scaling sequencing operations in molecular labs, plus how to keep trust in AI-assisted variant interpretation. |
Natera San Carlos, CA | |
Cell-free DNA testing company; Signatera is a custom ctDNA test for molecular residual disease assessment and treatment monitoring. | Booth Exhibiting at Booth 445 Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm Workshop Wed, Nov 11 4:00pm–4:50pm Title: Advancements in MRD Testing: The Expanding Role of Digital Pathology and AI Digital pathology and machine learning applied to specimen assessment and interpretation in residual disease testing. |
Foundation Medicine Boston, MA | |
Molecular information company providing comprehensive genomic profiling to inform cancer treatment decisions. | Booth Exhibiting at Booth 1701, MR14 Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm Workshop Wed, Nov 11 8:00am–8:50am Molecular Residual Disease in Breast Cancer: Advancing Surveillance and Clinical Decision-Making Tissue-informed circulating tumor DNA testing in breast cancer, from baseline through surveillance and early recurrence detection. Workshop Wed, Nov 11 9:00am–9:50am Advancing HLA Class I Typing Through Comprehensive Genomic Profiling Adding HLA class I typing to comprehensive genomic profiling, with immuno-oncology uses from checkpoint inhibitors to cell therapy. Talk Thu, Nov 12 7:15am–8:15am Adapting Communication Strategies for Today's Pathology Learners (A Special EdCoP Event) Teaching pathology trainees across generations and learning styles, including feedback and handling performance problems. |
Arima Genomics Carlsbad, CA | |
Cancer diagnostics from whole-genome sequence and structure; runs the CLIA-certified Aventa clinical lab and supplies research kits and informatics. | Booth Exhibiting at Booth 536 Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm Workshop Wed, Nov 11 2:00pm–2:50pm Aventa Clinical Testing Powered by Arima Hi-C: Revealing Actionable Genomic Structure Across Lymphoma, Lung Cancer, and Sarcoma Hi-C sequencing of FFPE tissue to map fusions and rearrangements in lymphoma, lung cancer and sarcoma cases. |
Inocras San Diego, CA | |
Whole-genome sequencing and AI-driven bioinformatics for cancer and rare disease, offering clinical testing and research data integration. | Booth Exhibiting at Booth 2305 Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm |
MRC Holland Amsterdam, Netherlands | |
Assays for gene copy number and methylation detection, including MLPA and digitalMLPA probemixes for hereditary disorders and tumour profiling. | Booth Exhibiting at Booth 643 Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm Workshop Wed, Nov 11 1:00pm–1:50pm Strategies for Optimizing Nucleic Acid Extraction in Molecular Oncology Workflows: Liquid Biopsy, FFPE, and Beyond Magnetic bead extraction tuned for high-throughput oncology workflows, covering FFPE tissue and cell-free DNA from plasma. |
CAP and CLIA certified laboratory offering cell-free DNA and RNA liquid biopsy testing for cancer. | Workshop Wed, Nov 11 1:00pm–1:50pm Advancing Cell-Free Nucleic Acid Testing: Integrated Workflows for Prenatal and Oncology Applications Cell-free DNA and RNA workflows for prenatal screening and oncology, including why DNA-only sequencing misses actionable fusions. |
Predicta Biosciences Cambridge, MA | |
Blood-cancer diagnostics company whose genome sequencing test on blood or bone marrow diagnoses and guides treatment of multiple myeloma. | Workshop Wed, Nov 11 12:00pm–12:50pm Next-Generation Sequencing with Roche’s AXELIOS 1 Platform Roche's AXELIOS 1 sequencer and its expansion-based chemistry, covering accuracy, read length and run flexibility. |
Univ8 Genomics Belfast, UK | |
Makes targeted NGS assays for leukaemia, lymphoma and myeloid cancers that detect clonality, translocations, copy number changes and mutations in one test. | Workshop Wed, Nov 11 11:00am–11:50am Automated and Integrated Genomic Profiling of Hematologic Malignancies Sequencing workflows for blood cancers that report mutations, structural variants and clonal evolution in one automated run. |
Bio-Techne Diagnostics Austin, TX | |
Supplies clinical labs and assay developers with amplification-based enrichment and long-read sequencing products for genetic and oncology testing. | Booth Exhibiting at Booth 737, 837 Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm Workshop Wed, Nov 11 11:00am–11:50am Deep Sensitivity Meets Workflow Efficiency: Optimizing HemOnc MRD Testing in Your Laboratory Quantitative PCR for myeloid residual disease, including laboratory experience validating a new PML-RARA kit and its workflow. |
Pillar Biosciences Natick, MA | |
Next-generation sequencing kits for cancer testing built on SLIMamp and PiVAT technologies, in research-use and in vitro diagnostic formats. | Booth Exhibiting at Booth 928, MR8 Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm Workshop Wed, Nov 11 10:00am–10:50am Rapid NGS That Scales: Clinical Implementation of oncoReveal® Myeloid NGS on the MiSeq i100 Bringing a myeloid sequencing panel in house on a benchtop sequencer, reaching roughly three-day turnaround across 200 samples. Workshop Wed, Nov 11 8:00am–8:50am Evaluation and Analytical Validation of a Rapid NGS Panel to Evaluate Lymphoid Malignancies Validating a rapid sequencing panel for lymphoid cancers, with wider gene coverage and shorter turnaround in a hospital lab. Workshop Wed, Nov 11 9:00am–9:50am Bringing Liquid Biopsy Closer to Patients: Rapid Local NGS Testing for Biomarker Assessment in Advanced Breast Cancer Running ctDNA testing locally for advanced breast cancer cuts turnaround, raising questions of validation, interpretation and quality control. |
APIS Assay Technologies Manchester, UK | |
qPCR and digital PCR assays for oncology and pharmacogenetics research, covering mutation detection, gene expression and genetic variants, using Clickmers aptamer technology. | Booth Exhibiting at Booth 2302 Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm |
Instantly find 20 buyers from diagnostics companies
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Browse AMP 2026 by
Organization type
Program track
Exhibit hall
Everyone
Not affiliated with the Association for Molecular Pathology. Organization details are derived from AMP’s published lists. Submit a correction